D J Triggle|V C Swamy - JoVE Visualize

Showing results (121-130 of 153) with videos related to

Pageof 16

Sort By:

Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1990

The interactions of 1,4-dihydropyridines bearing a 2-(2-aminoethylthio)methyl substituent at voltage-dependent Ca2+ channels of smooth muscle, cardiac muscle and neuronal tissuesY W Kwon, Q Zhong, X Y Wei, et al.

Il Farmaco; Edizione Scientifica|July 1, 1978

Molecular properties of the adrenergic alpha-receptor. I--Structural requirements for specific covalent occupancy by N,N'-bis--(5-aminopentyl)cystamine derivativesY Ueda, C Melchiorre, B Lippert, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 1, 1984

Distinction between high-affinity [3H]phencyclidine binding sites and muscarinic receptors in guinea-pig ileum muscleE E El-Fakahany, D J Triggle, A T Eldefrawi, et al.

Journal of Medicinal Chemistry|August 17, 1999

Lipophilic 4-isoxazolyl-1,4-dihydropyridines: synthesis and structure-activity relationshipsN R Natale, M E Rogers, R Staples, et al.

Journal of Medicinal Chemistry|February 1, 1982

Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridineR Fossheim, K Svarteng, A Mostad, et al.

The Journal of Biological Chemistry|February 25, 1984

Subcellular distribution of [3H]nitrendipine binding in smooth muscleA K Grover, C Y Kwan, E Luchowski, et al.

Drug Design and Discovery|July 1, 1992

QSAR, diagnostic statistics and molecular modelling of 1,4-dihydropyridine calcium antagonists: a difficult road aheadP P Mager, R A Coburn, A J Solo, et al.

Pharmaceutical Research|November 1, 1992

Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonistsD J Triggle, Y W Kwon, P Abraham, et al.

Journal of Medicinal Chemistry|February 1, 1988

Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) seriesR Fossheim, A Joslyn, A J Solo, et al.

Biochemical Pharmacology|February 15, 1988

Regulation by chronic drug administration of neuronal and cardiac calcium channel, beta-adrenoceptor and muscarinic receptor levelsP Gengo, A Skattebøl, J F Moran, et al.

Pageof 16

Showing results (121-130 of 153) with videos related to

Sort By:

Pageof 16

Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1990

The interactions of 1,4-dihydropyridines bearing a 2-(2-aminoethylthio)methyl substituent at voltage-dependent Ca2+ channels of smooth muscle, cardiac muscle and neuronal tissuesY W Kwon, Q Zhong, X Y Wei, et al.

Il Farmaco; Edizione Scientifica|July 1, 1978

Molecular properties of the adrenergic alpha-receptor. I--Structural requirements for specific covalent occupancy by N,N'-bis--(5-aminopentyl)cystamine derivativesY Ueda, C Melchiorre, B Lippert, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 1, 1984

Distinction between high-affinity [3H]phencyclidine binding sites and muscarinic receptors in guinea-pig ileum muscleE E El-Fakahany, D J Triggle, A T Eldefrawi, et al.

Journal of Medicinal Chemistry|August 17, 1999

Lipophilic 4-isoxazolyl-1,4-dihydropyridines: synthesis and structure-activity relationshipsN R Natale, M E Rogers, R Staples, et al.

Journal of Medicinal Chemistry|February 1, 1982

Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 2-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridineR Fossheim, K Svarteng, A Mostad, et al.

The Journal of Biological Chemistry|February 25, 1984

Subcellular distribution of [3H]nitrendipine binding in smooth muscleA K Grover, C Y Kwan, E Luchowski, et al.

Drug Design and Discovery|July 1, 1992

QSAR, diagnostic statistics and molecular modelling of 1,4-dihydropyridine calcium antagonists: a difficult road aheadP P Mager, R A Coburn, A J Solo, et al.

Pharmaceutical Research|November 1, 1992

Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonistsD J Triggle, Y W Kwon, P Abraham, et al.

Journal of Medicinal Chemistry|February 1, 1988

Crystal structures and pharmacologic activities of 1,4-dihydropyridine calcium channel antagonists of the isobutyl methyl 2,6-dimethyl-4-(substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylate (nisoldipine) seriesR Fossheim, A Joslyn, A J Solo, et al.

Biochemical Pharmacology|February 15, 1988

Regulation by chronic drug administration of neuronal and cardiac calcium channel, beta-adrenoceptor and muscarinic receptor levelsP Gengo, A Skattebøl, J F Moran, et al.

Pageof 16